Regina Groves

Track

Insider profile

Currently holds a position at AtriCure Inc

Performance

Overall performance
2.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 50% 68% 82%
Transactions
7 29% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 55%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Director AtriCure Inc March 21, 2017 -
Chief Executive Officer, Director REVA Medical Inc June 1, 2017 - Jan. 27, 2019
Chief Executive Officer, Principal Executive Officer REVA Medical Inc Sept. 21, 2015 - June 1, 2017
Regina Groves's trades of AtriCure Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US AtriCure Inc (ATRC)
Transaction date
Sale
Price
297.44
Quantity 74,172 -4.4%
Value US$2,986,503
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
321.85
Quantity 46,938
Value US$2,587,128
US AtriCure Inc (ATRC)
Transaction date
Sale
Price
294.24
Quantity 98,152 +24.8%
Value US$4,424,344
US AtriCure Inc (ATRC)
Transaction date
Proposed sale
Price
36.83
Quantity 2,452
Value US$90,307
US AtriCure Inc (ATRC)
Transaction date
Sale
Price
74.73
Quantity 3,156 -16.3%
Value US$235,848
US AtriCure Inc (ATRC)
Transaction date
Sale
Price
71.95
Quantity 4,208 -17.9%
Value US$302,766
US AtriCure Inc (ATRC)
Transaction date
Purchase
Price
76.68
Quantity 34 +0.2%
Value US$2,607
US AtriCure Inc (ATRC)
Transaction date
Sale
Price
41.83
Quantity 6,313 -22.4%
Value US$264,073
US AtriCure Inc (ATRC)
Transaction date
Purchase
Price
24.86
Quantity 500 +2.0%
Value US$12,430
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-14 2026-09-11
US AtriCure Inc (ATRC)
S Sale
74,172 -4.4%
297.44
US$2,986,503 		74,172 -4.4% 297.44 US$2,986,503
2026-09-11 2026-09-10
US AtriCure Inc (ATRC)
PrS Proposed sale
46,938
321.85
US$2,587,128 		46,938 321.85 US$2,587,128
2025-08-08 2025-08-06
US AtriCure Inc (ATRC)
S Sale
98,152 +24.8%
294.24
US$4,424,344 		98,152 +24.8% 294.24 US$4,424,344
2025-08-06 2025-08-06
US AtriCure Inc (ATRC)
PrS Proposed sale
2,452
36.83
US$90,307 		2,452 36.83 US$90,307
2021-09-17 2021-09-15
US AtriCure Inc (ATRC)
S Sale
3,156 -16.3%
74.73
US$235,848 		3,156 -16.3% 74.73 US$235,848
2021-05-28 2021-05-26
US AtriCure Inc (ATRC)
S Sale
4,208 -17.9%
71.95
US$302,766 		4,208 -17.9% 71.95 US$302,766
2021-10-29 2021-04-30
US AtriCure Inc (ATRC)
B Purchase
34 +0.2%
76.68
US$2,607 		34 +0.2% 76.68 US$2,607
2020-09-16 2020-09-14
US AtriCure Inc (ATRC)
S Sale
6,313 -22.4%
41.83
US$264,073 		6,313 -22.4% 41.83 US$264,073
2019-09-16 2019-09-12
US AtriCure Inc (ATRC)
B Purchase
500 +2.0%
24.86
US$12,430 		500 +2.0% 24.86 US$12,430